Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients.
OBJECTIVE
For the normalization of serum magnesium (Mg) concentration, dialysate Mg concentration tends to be reduced in continuous ambulatory peritoneal dialysis (CAPD) patients. The aim of this study was to evaluate the influence of Mg on parathyroid hormone (PTH).


METHODS
Prospective study of the utilization of Mg-free dialysate for 8 weeks.


METHODS
Dialysis service, Itabashi Hospital, Nihon University School of Medicine.


METHODS
Five stable CAPD patients (1 male; 4 female; age 49.7 +/- 1.3 years; duration of CAPD 27 +/- 9 months).


METHODS
Serum Mg, serum high sensitive PTH, and Mg content in mononuclear cells were measured at 4-week intervals.


RESULTS
In comparison to baseline, serum Mg concentration was significantly reduced at week 4 (p < 0.01) and week 8 (p < 0.01), and serum PTH was significantly increased at week 4 (p < 0.05) and at week 8 (p < 0.05). However, the PTH level at week 8 was lower than that at week 4. Furthermore, the Mg content in mononuclear cells was significantly decreased at week 4 (p < 0.01) and at week 8 (p < 0.01). Serum-ionized calcium and phosphate concentrations did not change.


CONCLUSIONS
The removal of Mg by Mg-free dialysate leads to Mg depletion in CAPD patients. In addition, Mg depletion stimulates PTH synthesis or secretion at 4 weeks, but at 8 weeks PTH synthesis or secretion is also influenced by other factors.
Takahashi
S
S
Nishi-Kofu National Hospital, Yamanashi, Japan.
Okada
K
K
Yanai
M
M
D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood; D003404:Creatinine / Q000097:blood; D015314:Dialysis Solutions / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000737:chemistry; D008214:Lymphocytes / Q000737:chemistry; D008274:Magnesium / Q000008:administration & dosage* / Q000097:blood* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods; D010710:Phosphates / Q000097:blood; D011446:Prospective Studies
D015314:Dialysis Solutions; D010281:Parathyroid Hormone; D010710:Phosphates; D003404:Creatinine; D008274:Magnesium; D002118:Calcium